Gateway™ pENTR™ 11 Dual Selection Vector
Gateway™ pENTR™ 11 Dual Selection Vector
Invitrogen™

Gateway™ pENTR™ 11 Dual Selection Vector

Gateway™ Eingabevektoren sind für das Klonen von DNA-Sequenzen mittels Restriktionsendonukleasen und Ligase zur Erstellung eines Gateway™ Entry-Klons konzipiert. Der resultierendeWeitere Informationen
Have Questions?
KatalognummerMenge
A1046710 μg
Katalognummer A10467
Preis (EUR)
149,00
Each
Zum Warenkorb hinzufügen
Menge:
10 μg
Preis (EUR)
149,00
Each
Zum Warenkorb hinzufügen
Gateway™ Eingabevektoren sind für das Klonen von DNA-Sequenzen mittels Restriktionsendonukleasen und Ligase zur Erstellung eines Gateway™ Entry-Klons konzipiert. Der resultierende Entry-Klon kann mit einem Zielvektor neu kombiniert werden, um einen Expressionsklon zu erstellen. Neu: pENTR™ Dual Selection-Vektoren!

Die Gateway™ Entry-Vektoren (Tabelle 1) bieten Folgendes:
• attL1- und attL2-Stellen für die stellenspezifische Rekombination des Entry-Klons mit einem Gateway™ Zielvektor, um das Klonen des Gens von Interesse in der richtigen Ausrichtung für die Expression zu gewährleisten
• Kozak Konsenssequenz zur effizienten Initiierung der Translation in eukaryotischen Systemen
• Ribosome Bindungsstelle für eine effiziente Initiierung der Translation in prokaryotischen Systemen (Nur pENTR™ 1A Dual Selection, pENTR™ 3C Dual Selection und pENTR™ 11 Dual Selection-Vektoren)
• Terminationssequenzen für die RrnB-Transkription zur Verhinderung einer basalen Expression des betreffenden PCR-Produkts bei E. coli
• pUC-Ursprung für hohe Replikation und Erhaltung des Plasmids in E. coli
• Kanamycin-Resistenzgen für die Selektion bei E. coli
• Das ccdB⁄Chloramphenicol-Fusionsgen zwischen den beiden attL-Stellen für eine
o-Negativselektion und
o-Chloramphenicol-Selektion in E. coli
•Kanamycin-Resistenzgen für die Selektion bei E. coli
Nur für Forschungszwecke. Nicht zur Verwendung bei diagnostischen Verfahren.
Specifications
Bakterielle AntibiotikaresistenzChloramphenicol (CmR), Kanamycin (KanR)
SpaltungKeine Spaltungsstelle
ProdukttypDual-SelectionExpression-Vektor
Menge10 μg
VektorpENTR
KlonierungsmethodeGateway™
ProduktliniepENTR
ProteinmarkierungNicht markiert
Unit SizeEach
Inhalt und Lagerung
10 µg pENTR™ Dual Selection-Vektor, in 20 μl im TE-Puffer, pH 8,0.
Bei -20 °C lagern

Häufig gestellte Fragen (FAQ)

How large of a PCR product can I recombine with a pDONR vector via BP cloning? Does the same apply for TOPO-adapted Entry vectors?

There is no theoretical limit to insert size for a BP reaction with a pDONR vector. Maximum size tested in-house is 12 kb. TOPO vectors are more sensitive to insert size and 3-5 kb is the upper limit for decent cloning efficiency.

How should I clean up my attB-PCR product?

After generating your attB-PCR product, we recommend purifying it to remove PCR buffer, unincorporated dNTPs, attB primers, and any attB primer-dimers. Primers and primer-dimers can recombine efficiently with the Donor vector in the BP reaction and may increase background after transformation into E. coli, whereas leftover PCR buffer may inhibit the BP reaction. Standard PCR product purification protocols using phenol/chloroform extraction followed by ammonium acetate and ethanol or isopropanol precipitation are not recommended for purification of the attB-PCR product as these protocols generally have exclusion limits of less than 100 bp and do not efficiently remove large primer-dimer products. We recommend a PEG purification protocol (see page 17 of the Gateway Technology with Clonase II manual). If you use the above protocol and your attB-PCR product is still not suitably purified, you may further gel-purify the product. We recommend using the PureLink Quick Gel Extraction kit.

I'm trying to propagate my Gateway destination vector and am not seeing any colonies. What should I do?

Check the genotype of the cell strain you are using. Our Gateway destination vectors typically contain a ccdB cassette, which, if uninterrupted, will inhibit E. coli growth. Therefore, un-cloned vectors should be propagated in a ccdB survival cell strain, such as our ccdB Survival 2 T1R competent cells.

What is the difference between LR Clonase II and LR Clonase II Plus?

LR Clonase II Plus contains an optimized formulation of recombination enzymes for use in MultiSite Gateway LR reactions. LR Clonase and LR Clonase II enzyme mixes are not recommended for MultiSite Gateway LR recombination reactions, but LR Clonase II Plus is compatible with both multi-site and single-site LR recombination reactions.

What is the purpose of the Proteinase K step following a Gateway LR Recombination reaction, and is it critical to the results?

When the LR reaction is complete, the reaction is stopped with Proteinase K and transformed into E. coli resulting in an expression clone containing a gene of interest. A typical LR reaction followed by Proteinase K treatment yields about 35,000 to 150,000 colonies per 20ul reaction. Without the Proteinase K treatment, up to a 10 fold reduction in the number of colonies can be observed. Despite this reduction, there are often still enough colonies containing the gene of interest to proceed with your experiment, so the Proteinase K step can be left out after the LR reaction is complete if necessary.